KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Molina Healthcare (MOH) EBIAT (2016 - 2025)

Molina Healthcare (MOH) has disclosed EBIAT for 16 consecutive years, with -$160.0 million as the latest value for Q4 2025.

  • Quarterly EBIAT fell 163.75% to -$160.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $472.0 million through Dec 2025, down 59.97% year-over-year, with the annual reading at $472.0 million for FY2025, 59.97% down from the prior year.
  • EBIAT hit -$160.0 million in Q4 2025 for Molina Healthcare, down from $79.0 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $326.0 million in Q3 2024 to a low of -$160.0 million in Q4 2025.
  • Historically, EBIAT has averaged $217.7 million across 5 years, with a median of $248.0 million in 2022.
  • Biggest five-year swings in EBIAT: surged 202.94% in 2021 and later crashed 163.75% in 2025.
  • Year by year, EBIAT stood at $103.0 million in 2021, then soared by 123.3% to $230.0 million in 2022, then fell by 6.09% to $216.0 million in 2023, then increased by 16.2% to $251.0 million in 2024, then plummeted by 163.75% to -$160.0 million in 2025.
  • Business Quant data shows EBIAT for MOH at -$160.0 million in Q4 2025, $79.0 million in Q3 2025, and $255.0 million in Q2 2025.